Dysport for smile lines: how it compares and what to expect
Smile lines (nasolabial folds and the creases that deepen with expression) are often treated with injectable options that relax specific facial muscles. Dysport is one of the most common prescription neuromodulators used for this purpose, and understanding how it differs from similar products can help you set realistic expectations for results, downtime, and ongoing maintenance.
Fine lines that form around the mouth and midface can become more noticeable over time, especially with repeated expressions, sun exposure, and natural changes in skin elasticity. Dysport is frequently discussed for softening dynamic wrinkles, but smile-line anatomy is complex, and outcomes depend on whether the lines are driven by muscle movement, skin laxity, volume loss, or a combination.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.
What Dysport is and how it works for smile lines
Dysport (abobotulinumtoxinA) is a prescription injectable that temporarily reduces the activity of targeted muscles by blocking nerve signals at the neuromuscular junction. When the muscles that contribute to certain expression lines relax, the overlying skin can appear smoother. For “smile lines,” it’s important to clarify what is being treated: deep nasolabial folds are often influenced by volume loss and facial structure, while adjacent perioral lines and movement-related creasing can respond more predictably to neuromodulators.
In practice, clinicians may use Dysport to address muscle-driven creases around the mouth region or to refine how the upper lip and surrounding muscles move. If a smile line is primarily a static fold (visible at rest), fillers, skin treatments, or a combined approach may be considered instead of—or in addition to—Dysport.
How Dysport compares with other neuromodulators
In terms of category, Dysport is similar to other botulinum toxin type A products used in aesthetics, such as Botox Cosmetic (onabotulinumtoxinA), Xeomin (incobotulinumtoxinA), and Jeuveau (prabotulinumtoxinA). They all aim to reduce dynamic wrinkles, but they differ in formulation, dosing units, and how clinicians may experience their “spread” or diffusion in certain areas.
A key point for comparison is that Dysport units are not equivalent to Botox units; conversion is not 1:1, and dosing decisions are product-specific. Some patients report a slightly faster onset with Dysport in certain regions, but individual response varies, and technique often matters more than brand. For smile-line-related concerns, precise placement is critical because the mouth area is highly expressive; overtreatment can affect symmetry, speech, or smiling comfort.
Who is a good candidate and contraindications
A good candidate is generally an adult in good health who has concerns about expression-related lines and understands that neuromodulators soften movement-driven wrinkles rather than dramatically changing underlying facial structure. The most suitable “smile line” cases tend to be those where muscle action significantly contributes to the creasing pattern.
Common reasons a clinician may advise against treatment, delay it, or proceed with extra caution include pregnancy or breastfeeding, a history of allergy to ingredients in the product, infection or inflammation at the injection site, or certain neuromuscular conditions. It’s also important to discuss medications and supplements that may increase bruising risk (such as anticoagulants or some anti-inflammatories), as well as prior facial procedures that could affect anatomy.
Treatment procedure: what to expect at an appointment
Appointments are typically brief and may start with a facial assessment at rest and during expression so the injector can map which muscles are contributing to the concern. The area is cleansed, and injections are delivered with a fine needle in small amounts. Discomfort is usually mild and short-lived, though sensitivity varies by person and by the specific injection points.
After treatment, you may have small bumps, redness, or pinpoint bruising that fades over hours to a few days. Many clinicians recommend avoiding rubbing the area, heavy exercise, or prolonged heat exposure for the rest of the day, since these can worsen swelling or bruising. For mouth-area injections in particular, following aftercare instructions matters because the muscles are active during talking, eating, and smiling.
Real-world pricing for Dysport and comparable neuromodulators is influenced by the country and city you’re in, clinician expertise, whether you’re charged per unit or per treatment area, and the total dose needed for your anatomy and goals. As a general benchmark, aesthetic neuromodulator pricing is often quoted per unit; however, Dysport uses different units than Botox, so unit price alone can be misleading—total expected cost should be discussed as an overall plan.
| Product/Service | Provider | Cost Estimation |
|---|---|---|
| Dysport (abobotulinumtoxinA) | Galderma | Often quoted around $4–$8 per Dysport unit; total cost varies by dose and region |
| Botox Cosmetic (onabotulinumtoxinA) | Allergan Aesthetics (AbbVie) | Commonly around $10–$20 per unit; total cost varies by dose and region |
| Xeomin (incobotulinumtoxinA) | Merz Aesthetics | Commonly around $10–$18 per unit; total cost varies by dose and region |
| Jeuveau (prabotulinumtoxinA) | Evolus | Commonly around $8–$16 per unit; total cost varies by dose and region |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
Results timeline, longevity, and maintenance
Initial changes are often noticed within a few days, with results typically settling over about 1–2 weeks as the neuromodulator reaches full effect. How long the effect lasts varies, but many people plan on maintenance treatments roughly every 3–4 months. Longevity can be influenced by dose, muscle strength, metabolism, the treated area, and how expressive the region is in daily life.
For smile-line-adjacent treatments, subtlety is often the goal: improving how lines look during expression while preserving natural movement. If you’re treating deeper folds, results may be incremental, and a clinician may recommend combining approaches (for example, neuromodulator plus filler or skin-focused treatments) based on whether the lines are dynamic, static, or structurally driven.
A practical way to set expectations is to think in terms of softening rather than erasing. When Dysport is used appropriately, the outcome is typically a refreshed look that still allows normal expression. The safest and most predictable results generally come from individualized assessment, conservative dosing, and a plan that accounts for the unique anatomy and function of the mouth area.